Bone seeking radiopharmaceuticals

[1]  P. Dubin,et al.  Aqueous size exclusion chromatography , 1989 .

[2]  W. J. Gelsema,et al.  The binding of 99mTc(Sn)-MDP complexes to human serum albumin and other blood proteins determined with gel chromatography and ultrafiltration. , 1989, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[3]  W. J. Gelsema,et al.  A (re)investigation of the influence of some metal ions on the mean size of 99mTc(Sn)-MDP constituents at neutral pH. , 1989, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[4]  H. A. Das,et al.  Improvement of the reproducibility of ion-pair HPLC of 99mTc(Sn)EHDP complexes and the influence of the Sn(II) concentration on the composition of the reaction mixture. , 1989, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[5]  D. E. Troutner,et al.  Adsorption of 153Sm-EDTMP on calcium hydroxyapatite , 1988 .

[6]  J. Kroesbergen,et al.  99mTc bone scanning agents--VI. Gel chromatographic analysis of the plasma protein binding of 99mTc(Sn)pyrophosphate, 99mTc(Sn)MDP and 99mTc(Sn)HMDP. , 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[7]  W. J. Gelsema,et al.  Anion exchange chromatography of 99mTc(Sn)-MDP complexes: influence of eluent composition, determination of void volume and charge of the main component. , 1988, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[8]  J. Kroesbergen,et al.  99mTc bone scanning agents--IV. Chemical characterization of 99mTc(Sn)-pyrophosphate complexes. , 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[9]  W. J. Gelsema,et al.  Effect of the composition of the eluent in the chromatography of 99mTc-diphosphonate complexes. , 1988, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[10]  C. Fenselau,et al.  Chemical aspects of fast atom bombardment , 1987 .

[11]  A. Nunn,et al.  Comparison of desorption ionization methods for the analysis of neutral seven-coordinate technetium radiopharmaceuticals. , 1987, Analytical chemistry.

[12]  R. A. Holmes,et al.  Skeletal localization of samarium-153 chelates: potential therapeutic bone agents. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  A. S. Posner,et al.  Surface poisoning of synthetic and biological apatites , 1987 .

[14]  T. Pinkerton,et al.  Molecular weights of technetium hydroxyethylidene diphosphonate complexes. , 1987, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[15]  M. Conti,et al.  The influence of the charge and of the tin-ligand ratio on bone uptake of technetium 99m labelled osteotropic radiopharmaceuticals. , 1987, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[16]  T. Pinkerton,et al.  Raman spectroscopic evidence for Tc-oxo cores in Tc-HEDP complexes. , 1987, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[17]  J. A. Spicer,et al.  Treatment of metastatic bone pain with strontium-89. , 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[18]  A. Ketring.  153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals. , 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[19]  W. J. Gelsema,et al.  Gel chromatographic analysis of the bone seeking radiopharmaceutical 99mTc(Sn)-EHDP: the influence of pH and EHDP-concentration on the size of its constituents. , 1987, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[20]  S. Adelstein,et al.  Radiobiologic implications of the microscopic distribution of energy from radionuclides. , 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[21]  E. Sundrehagen,et al.  Determination of the oxidation state of 99mTc in complexes with MDP and DTPA. , 1987, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[22]  D. E. Troutner.  Chemical and physical properties of radionuclides. , 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[23]  R. Grouls,et al.  Binding of 99mTc(113Sn)-MDP to human serum albumin. The influence of various technetium, tin, and MDP concentrations. , 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[24]  A. Nunn,et al.  X-ray photoelectron spectroscopy of potential technetium-based organ imaging agents , 1986 .

[25]  A. Kovalík,et al.  Oxidation states of technetium 99m in technetium chelates studied by the ices method , 1986 .

[26]  T. Pinkerton,et al.  Liquid chromatography of tin-reduced technetium hydroxyethylidene diphosphonate complexes for on-line spectral characterization and double isotope labeling. , 1986, Analytical chemistry.

[27]  G. Bandoli,et al.  Technetium in chemistry and nuclear medicine, 2 , 1986 .

[28]  A. Kovalík,et al.  Oxidation states of 99mTc in technetium chelates studied by the ICES method , 1986 .

[29]  H. A. Das,et al.  The effect of DMSO treatment on the composition of 99mTc(Sn)EHDP. , 1986, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[30]  W. Heineman,et al.  The effect of formulation conditions on the distribution of 99mTc(NaBH4)-HEDP components separated by anion exchange HPLC. , 1986, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[31]  J. Vanderheyden,et al.  The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. , 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[32]  H. A. Das,et al.  The separation of 99mTc(Sn)EHDP complexes by HPLC and GPC. , 1986, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[33]  W. Volkert,et al.  153Sm radiotherapeutic bone agents. , 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[34]  K. Cheng,et al.  Influence of complex charge and size on the uptake of 99mTc-diphosphonates in osteogenic tissue. , 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[35]  T. Pinkerton,et al.  Bioinorganic activity of technetium radiopharmaceuticals , 1985 .

[36]  N. Hutchison,et al.  Electrophoretic analysis of different technetium-99m (SnCl2) methylene diphosphonate complexes. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  A. Kovalík,et al.  Determination of 99mTc valent form in solids by measurement of internal conversion electrons , 1985 .

[38]  J. Schmitz,et al.  The oxidation of Sn(II) diphosphonates by pertechnetate followed with differential pulse polarography and mössbauer spectroscopy , 1985 .

[39]  S. Vilcek,et al.  99mTc-labelled compounds prepared with tungsten(III) as the reducing agent , 1985 .

[40]  N. Alberola,et al.  Spectrometrie RMN 31P, 119Sn et 99Tc d'une solution aqueuse mixte d'EHDP, d'étain et de technetium , 1985 .

[41]  R. S. Mani.  Research reactor production of radioisotopes for medical use , 1985 .

[42]  T. Pinkerton,et al.  Determination of charge and size of technetium diphosphonate complexes by anion-exchange liquid chromatography , 1985 .

[43]  N. Albérola.  119mSn Mössbauer spectroscopy and 31P and 119Sn NMR of mixed aqueous 1-hydroxy ethylidene-1,1-disodium phosphonate (EHDP) and tin(II) chl , 1985 .

[44]  R. Grouls,et al.  Protein-binding and urinary excretion of 99mTc(Sn)-MDP and 99mTc-MDP. , 1985, International journal of nuclear medicine and biology.

[45]  N. Priest.  Metals in Bone , 1985, Springer Netherlands.

[46]  J. Steigman,et al.  Extraction of Tc(V) from Radiopharmaceuticals , 1984 .

[47]  C. Russell,et al.  Mean ionic charge on two components of technetium pyrophosphate prepared using stannous chloride. , 1984, The International journal of applied radiation and isotopes.

[48]  S. Duursma,et al.  Electrolytically labeled [99mTc]MDP: chromatographic pattern, stability and biodistribution in rats. , 1984, The International journal of applied radiation and isotopes.

[49]  A. Ketring,et al.  186Re-HEDP: a potential therapeutic bone agent. , 1984, Nuklearmedizin. Nuclear medicine.

[50]  S. Vilcek,et al.  99mTc-labelled compounds prepared with molybdenum III as reducing agent. , 1984, The International journal of applied radiation and isotopes.

[51]  C. Kuni,et al.  Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[52]  L. Lindoy,et al.  Technetium Chemistry and Technetium Radiopharmaceuticals , 2007 .

[53]  W. Heineman,et al.  The biological distributions of some technetium-MDP components isolated by anion exchange high performance liquid chromatography. , 1983, The international journal of applied radiation and isotopes.

[54]  W. Heineman,et al.  Effect of pH on the formation of Tc(NaBH4)-MDP radiopharmaceutical analogues. , 1983, The International journal of applied radiation and isotopes.

[55]  F. D. Thomas,et al.  New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate. , 1983, Radiology.

[56]  W. Heineman,et al.  The electrochemical reduction of pertechnetate in aqueous hydroxyethylidene diphosphonate media , 1983 .

[57]  C. L. D. Ligny,et al.  Influence of Salt Composition, Ionic Strength, and pH of Eluent on the Distribution Coefficient of Ribonuclease in Gel Permeation Chromatography , 1983 .

[58]  Alun G. Jones,et al.  The chemistry of technetium I, II, III and IV , 1982 .

[59]  H. A. Das,et al.  The influence of the method of preparation of the bone scanning agent 99mTc(Sn)EHDP on its tissue distribution in the rat. , 1982, The International journal of applied radiation and isotopes.

[60]  C. L. D. Ligny,et al.  On the Influence of pH and Salt Composition on the Partition of Polyelectrolytes in Aqueous Polymer Two-Phase Systems , 1982 .

[61]  Alun G. Jones,et al.  Chemistry of technetium (V) , 1982 .

[62]  C. L. D. Ligny,et al.  The Influence of the Salt Composition of the Eluent on the Distribution Coefficient of Bovine Serum Albumin in Gel Permeation Chromatography at Low pH , 1981 .

[63]  H. A. Das,et al.  Gel chromatographic separation and identification of the Tc(Sn)EHDP complexes using the radiotracers 32P, 99(m)Tc, 113Sn , 1981 .

[64]  J. den Hartigh,et al.  Valence state of technetium in technetium methylene diphosphonate at tracer concentrations, measured by amperometry. , 1981, The International journal of applied radiation and isotopes.

[65]  L. Rosenthall,et al.  A Crossover Study Comparing Tc-99m-labeled HMDP and MDP in Patients , 1981, Clinical nuclear medicine.

[66]  S. Vilcek,et al.  compounds prepared with chrome(II) as reducing agent , 1981 .

[67]  E. Silberstein.  A radiopharmaceutical and clinical comparison of 99mTc-Sn-hydroxymethylene diphosphonate with 99mTc-Sn-hydroxyethylidene diphosphonate. , 1980, Radiology.

[68]  M. Francis,et al.  Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[69]  B. Dekker,et al.  The valence state of technetium-99 in its complexes with bleomycin, 1-hydroxy-ethylidene-1,1-diphosphonate and human serum albumin. , 1980, The International journal of applied radiation and isotopes.

[70]  B. Barnett,et al.  Structural characterization of a /sup 99/Tc-diphosphonate complex. Implications for the chemistry of /sup 99m/Tc skeletal imaging agents , 1980 .

[71]  N. D. Charkes.  Skeletal blood flow: implications for bone-scan interpretation. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[72]  M. Berger,et al.  Preparation of rhenium-186 labelled EHDP and its possible use in the treatment of osseous neoplasms. , 1979, The International journal of applied radiation and isotopes.

[73]  C. Russell,et al.  Oxidation state of technetium in bone scanning agents as determined at carrier concentration by amperometric titration. , 1979, The International journal of applied radiation and isotopes.

[74]  V. Hlady,et al.  Adsorption of human serum albumin on precipitated hydroxyapatite , 1979 .

[75]  W. Greig,et al.  A clinical comparison of Tc-99m HEDP and Tc-99m MDP in the detection of bone metastases: concise communication. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[76]  G. Meinken,et al.  The reduction of pertechnetate-99 by stannous chloride—II. The stoichiometry of the reaction in aqueous solutions of several phosphorus(V) compounds☆ , 1978 .

[77]  R. Münze.  Verbindungen des Technetiums(IV) mit Hydroxyäthylidendiphosphon säure , 1978 .

[78]  S. Hughes,et al.  Fluid space in bone. , 1978, Clinical orthopaedics and related research.

[79]  S. A. Grubb,et al.  The presence of lining cells on surfaces of human trabecular bone. , 1978, Clinical orthopaedics and related research.

[80]  S. K. Shukla.  Reduction of pertechnetate-99m ion by hydrochloric acid , 1978 .

[81]  G. Bahr,et al.  Clinical comparison of technetium-99m diphosphonate and pyrophosphate in bone scintigraphy: concise communication. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[82]  P. Kelly,et al.  Studies on bone ion exchanges using multiple-tracer indicator-dilution techniques. , 1977, Federation proceedings.

[83]  D. Citrin,et al.  A Clinical Comparison of 99mTc-Hydroxyethylidene Diphosphonate (H.E.D.P.) and 99mTc-Pyrophosphate in the Detection of Bone Metastases , 1977 .

[84]  J. Willerson,et al.  Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues. , 1977, The Journal of clinical investigation.

[85]  G. T. Krishnamurthy,et al.  Pharmaco-kinetics of current skeletal-seeking radiopharmaceuticals. , 1976, AJR. American journal of roentgenology.

[86]  G. Coates,et al.  An analysis of factors which influence the local accumulation of bone-seeking radiopharmaceuticals. , 1975, Investigative radiology.

[87]  P. Valk,et al.  Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[88]  W. Greig,et al.  A comparison of phosphate bone-scanning agents in normal subjects and patients with malignant disease. , 1975, The British journal of radiology.

[89]  A. Serafini,et al.  Bone scintigraphy--comparison of 99mTc-polyphosphate and 99mTc-diphosphonate. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[90]  Biologic Behavior.  FOR MEDICAL USE. , 1974 .

[91]  J. Chalmers.  Calcium, Parathyroid Hormone and the Calcitonins , 1973 .

[92]  K. Lee.  Hard tissue growth, repair and remineralization , 1973 .

[93]  E. Silberstein,et al.  Imaging of Bone Metastases with 99mTc-Sn-EHDP (Diphosphonate), 18F, and Skeletal Radiography , 1973 .

[94]  G. Boyd,et al.  Recent Developments in the Analytical Chemistry of Rhenium and Technetium , 1970 .